International Session(Panel Discussion)1(JGES・JSGE・JSGS・JSGCS)
Sat. November 4th   14:00 - 17:00   Room 9: Portopia Hotel Main Building Kairaku 3
IS-PD1-Keynote Lecture
Progress and future perspective of Inflammatory Bowel Disease
Shu Chen Wei
Department of Internal Medicine, National Taiwan University Hospital
IBDs become more prevalent worldwide, although the incidence seems to be stabilized or even decreased in some Western countries, the incidence is still uprising in Asian countries. The cost for caring IBD patients will increase. To spend the money on a knife-edge is the issue that the stake-holder need to be considered.
With the progress of advanced therapy, the choices become complex and the sequence of treatment might affect the outcomes. On the other side, therapeutic ceiling was observed, and how to break the ceiling need further effort. When the bars of treatment goals raising higher, though the evidence of histologic or even transmural healing are under accumulation, we need to answer the basic questions such as the definition, validation and cost/benefit/risk analysis at first.
Non-invasive monitoring remains the preferred method, but how to find a test with acceptable cost, widely available and correlating with mucosal status is still an unmet need. Recently, intestinal ultrasound becomes more and more popular for disease activity monitoring. However, there are still barriers need to be solved in order to get it used as a point of care tool, especially in Asian countries.
Lastly, enhanced image technique and artificial intelligence application are also hot topics. Currently, they are not in real world practice yet; but in the future, they will enter our daily practice for sure.
Index Term 1: progress
Index Term 2: Inflammatory Bowel Disease
Page Top